000 | 01035 a2200313 4500 | ||
---|---|---|---|
005 | 20250517003604.0 | ||
264 | 0 | _c20150804 | |
008 | 201508s 0 0 eng d | ||
022 | _a1750-7448 | ||
024 | 7 |
_a10.2217/imt.14.73 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWard, Frank J | |
245 | 0 | 0 |
_aTargeting the alternatively spliced soluble isoform of CTLA-4: prospects for immunotherapy? _h[electronic resource] |
260 |
_bImmunotherapy _c2014 |
||
300 |
_a1073-84 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAlternative Splicing |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCTLA-4 Antigen _ximmunology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunotherapy |
650 | 0 | 4 |
_aProtein Isoforms _ximmunology |
700 | 1 | _aDahal, Lekh N | |
700 | 1 | _aKhanolkar, Rahul C | |
700 | 1 | _aShankar, Sucharita P | |
700 | 1 | _aBarker, Robert N | |
773 | 0 |
_tImmunotherapy _gvol. 6 _gno. 10 _gp. 1073-84 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2217/imt.14.73 _zAvailable from publisher's website |
999 |
_c24383949 _d24383949 |